Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
15 août 2024 09h00 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Specialty Pharma Market Report 2024-2034: Specialty Pharmaceutical Market Surges in Global Spending Landscape
15 août 2024 05h33 HE
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Specialty Pharma Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Specialty Pharma Market is set to...
AI in Drug Discovery Market: $0.9B to $4.9B Growth Forecast (2023-2028) | MarketsandMarkets™
14 août 2024 08h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "AI in Drug Discovery Market Size, Share & Trends by Offering, Process (Target selection, Validation, Lead generation, optimization), Drug Design...
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
13 août 2024 07h00 HE
|
atai Life Sciences
VLS-01 demonstrated a good safety and tolerability profile and a short psychedelic experience, enabling a total in-clinic treatment of two hours.
Floor POP Display Market to Reach US$ 9.4 Billion at a CAGR of 6.3% by 2034 | Fact.MR Report
12 août 2024 07h30 HE
|
FACT.MR
Rockville, MD, Aug. 12, 2024 (GLOBE NEWSWIRE) -- According to a recently updated industry report by Fact.MR, a market research and competitive intelligence provider, the global floor POP display...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2024
09 août 2024 15h11 HE
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - July 2024
09 août 2024 15h11 HE
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Cell Therapy Biomanufacturing Market Report 2024: Market Revenue Data from 2022, Estimates for 2023, Forecasts for 2024 and Projected CAGRs through 2029
09 août 2024 05h41 HE
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Biomanufacturing Market 2024-2029" report has been added to ResearchAndMarkets.com's offering. The cell therapy biomanufacturing global...
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08 août 2024 08h00 HE
|
Phathom Pharmaceuticals
Over 122,000 prescriptions for VOQUEZNA® products written by healthcare providers, launch to date, a 184% increase since last quarterly reportNet revenues of $7.3 million reported for the second...
Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
07 août 2024 07h00 HE
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update